• Home
  • News
  • Norway: Gene therapeutic vaccines exempted from regulation

Norway: Gene therapeutic vaccines exempted from regulation

Gene therapeutic prophylactic vaccines are being exempted from regulation in the Biotechnology Act. This will have major consequences for the approval and administration of vaccines based on a new genetic engineering platform. Which, among other things, will have an impact on pandemic vaccines, e.g. vaccine against Covid-19.

Which means that the Norwegian population may be subject to vaccination with an experimental genetic engineering vaccine based on legislation that has been modified in such a way that one legally adds facilitate legal experimental, possible compulsory vaccination with a vaccine whose clinical studies had not yet been completed at the time the decision to amend the law was available.

Who we are

The EFVV (European Forum for Vaccine Vigilance) is an alliance of member-organisations and individual members from 25 European countries.  Our member-organisations consist of consumer groups and pro-choice groups whose members in turn include medical professionals and scientists. Their combined memberships exceed 100,000. We call on all Europeans to stand together in a demand for a united vaccination policy based on freedom of choice and informed consent.  We believe that mandatory vaccination is not only a serious risk but a violation of human rights and dignity.  We therefore demand transparency and caution as well as recognition and concern for the many vaccine-injured in Europe and beyond.

Contact Us


2021 © EFVV - European Forum for Vaccine Vigilance